Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-01

Clinical Trial Update: Adding Nalbuphine for Control of Intrathecal Morphine Pruritus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring nalbuphine to control intrathecal morphine–induced pruritus in postoperative patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intrathecal morphine (morphine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Minia University | Conditions: Pruritus, Pain, Postoperative | Phase 2 | Status: UNKNOWN